VeriMomБезопасен ли magnolia officinalis bark extract при беременности?
No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
Pregnancy-safe products containing magnolia officinalis bark extract
Related ingredients
Frequently asked questions
- Безопасен ли magnolia officinalis bark extract при беременности?
- No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
- Безопасен ли magnolia officinalis bark extract при грудном вскармливании?
- No harmonised reproductive/breastfeeding hazard classification or EU cosmetic ban/restriction was identified. Human data on passage into breast milk are not available; animal studies at high oral doses show organ effects but do not document lactation-specific transfer. Topical use could result in low systemic exposure; therefore risk from topical cosmetic use is expected to be low but incompletely characterised. (Sources: ECHA; PubMed toxicity reviews; WebMD/CanABaby summaries).
- Безопасен ли magnolia officinalis bark extract для кожи малыша?
- Hazard and mechanism scores unchanged (no evidence of reproductive/developmental or endocrine-disrupting classification). Exposure score increased by +1 for infants because topical botanical extracts can be absorbed more on immature infant skin; therefore if adult topical exposure is low-measurable (1), infant exposure is moderate (2). No infant-specific dermal toxicity or developmental studies were located. (Sources: ECHA; infant-safety summaries; topical absorption rationale).
- Как VeriMom оценивает magnolia officinalis bark extract?
- VeriMom оценивает magnolia officinalis bark extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы magnolia officinalis bark extract при беременности?
- См. наш список безопасных альтернатив magnolia officinalis bark extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.